Julpharma Formulations India Private Limited

Julpharma Formulations India Private Limited - chemicals in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U24304TG2017PTC117183 Incorporated 19 May 2017 ROC Hyderabad HQ Hyderabad, Telangana, India
Struck Off Private Limited Company chemicals
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
GST registrations
1
None active
Last financials
Mar 2020
Balance sheet date
Last AGM
25 Nov 2020
Annual general meeting
Company status
Struck Off
MCA master data

About Julpharma Formulations India Private Limited

Data last updated:

Julpharma Formulations India Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the formulations segment of the chemicals sector. It was incorporated on 19 May 2017.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC117183. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Anuradha Gundlapalli and Gopikrishna Gundlapalli.

Its last annual general meeting (AGM) was held on 25 November 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at H.No.8 – 3 – 236/1 Flat No.403 Yousufguda, Hyderabad, Telangana, India – 500045.

Company details

CIN U24304TG2017PTC117183
Registration Number 117183
Incorporation Date 19 May 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 25 November 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant

Contact details

Julpharma Formulations India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H.No.8 – 3 – 236/1 Flat No.403 Yousufguda, Hyderabad, Telangana, India – 500045
  • Industry
    Chemicals, Formulations

To see the full contact details of Julpharma Formulations India Private Limited, buy the company report.

Comprehensive company report
Julpharma Formulations India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Julpharma Formulations India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Julpharma Formulations India Private Limited, buy the company report.

Financials of Julpharma Formulations India Private Limited

FY 2020 filings available

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Julpharma Formulations India Private Limited, buy the company report.

Board of directors of Julpharma Formulations India Private Limited

Julpharma Formulations India has 2 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Anuradha GundlapalliDirector19 May 20179 Years 5 MonthsAs last reported
Gopikrishna GundlapalliDirector19 May 20179 Years 5 MonthsAs last reported

MSME payment delays

No delayed payments to MSME suppliers are on our record for Julpharma Formulations India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Julpharma Formulations India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Julpharma Formulations India Private Limited, buy the company report.

Recent activity

Julpharma Formulations India Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anuradha Gundlapalli was appointed as Director on 19 May 2017.

AGM
Julpharma Formulations India Private Limited last Annual general meeting of members was held on 25 Nov 2020 as per latest MCA records.
Filing
Julpharma Formulations India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Appointed
Anuradha Gundlapalli was appointed as Director.
Appointed
Gopikrishna Gundlapalli was appointed as Director.
Incorporation
19 May 2017
Julpharma Formulations India Private Limited was registered on 19 May 2017 with Roc Hyderabad & aged 9 years 5 months as per MCA records.

Frequently asked questions

Julpharma Formulations India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Julpharma Formulations India was a private limited company based in Hyderabad, Telangana, India. The company worked in formulations, within the chemicals industry. It was incorporated on 19 May 2017 and is registered under CIN U24304TG2017PTC117183. The company has been struck off by the Registrar of Companies and is no longer operational.

Julpharma Formulations India had 2 directors:

The CIN (Corporate Identification Number) of Julpharma Formulations India is U24304TG2017PTC117183. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Julpharma Formulations India is at H.No.8 – 3 – 2361 Flat No.403 Yousufguda, Hyderabad, Telangana, India – 500045.

Julpharma Formulations India was incorporated on 19 May 2017. It is registered with the Registrar of Companies, Hyderabad.

The latest financial statements of Julpharma Formulations India on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 25 November 2020. Year-wise statements from FY 2018 are in the company report.

No. Julpharma Formulations India has 1 GST registration on record and it is cancelled or inactive.

Julpharma Formulations India operated in the chemicals industry, in the formulations segment. It worked in this industry before it was struck off.

Anuradha Gundlapalli was appointed as Director on 19 May 2017. Gopikrishna Gundlapalli was appointed as Director on 19 May 2017.